Array BioPharma Inc.
Overview
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs to treat cancer and other high-burden diseases. In 2019, Array BioPharma became a subsidiary of Pfizer Inc., broadening Pfizer's oncology portfolio.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Array BioPharma Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.